Tada, you and I obviously have different views around what drives or doesn't drive the share price for RVX. I'm actually not trying to be excessively negative about certain aspects of this company but I thought this is a discussion forum not a cheerleading section.  I have said numerous times I think the science is fantastic at RVX.

In short though as far as effect on potential investors goes, I don't think there is anything "negative" that I or anyone else has been saying that could not be counteracted by management consistently employing some good basic business practices. To me if management straightened out company finances and started regularly communicating/following through accurately the share price would likely respond in step. One challenge for management in this regard is that they have not earned a "they've got this" reputation with investors and as such investors place no faith in just management's words.

Right now I think we all agree that there is a ton of commercial potential in the RVX science.  Management however must remember that investors invest to make money and that the only way investors at large are going to share management's "excitement" is when investors can clearly see what's in it for them should the science deliver on its potential.  Until that clarity is achieved I don't see much change in share price, exception being the potential for a run of irrational exuberance if the CoVid trial is a big success.